118 related articles for article (PubMed ID: 37603464)
21. Neutralizing tumor-promoting inflammation with polypeptide-dexamethasone conjugate for microenvironment modulation and colorectal cancer therapy.
Ma S; Song W; Xu Y; Si X; Zhang D; Lv S; Yang C; Ma L; Tang Z; Chen X
Biomaterials; 2020 Feb; 232():119676. PubMed ID: 31896516
[TBL] [Abstract][Full Text] [Related]
22. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
23. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.
Mpekris F; Papageorgis P; Polydorou C; Voutouri C; Kalli M; Pirentis AP; Stylianopoulos T
J Control Release; 2017 Sep; 261():105-112. PubMed ID: 28662901
[TBL] [Abstract][Full Text] [Related]
24. Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.
Chen Q; Zhang L; Li L; Tan M; Liu W; Liu S; Xie Z; Zhang W; Wang Z; Cao Y; Shang T; Ran H
J Nanobiotechnology; 2021 Dec; 19(1):449. PubMed ID: 34952587
[TBL] [Abstract][Full Text] [Related]
25. Microfluidic Sonication To Assemble Exosome Membrane-Coated Nanoparticles for Immune Evasion-Mediated Targeting.
Liu C; Zhang W; Li Y; Chang J; Tian F; Zhao F; Ma Y; Sun J
Nano Lett; 2019 Nov; 19(11):7836-7844. PubMed ID: 31597431
[TBL] [Abstract][Full Text] [Related]
26. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers.
Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X
Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162
[No Abstract] [Full Text] [Related]
27. Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.
Wang M; Hu Q; Huang J; Zhao X; Shao S; Zhang F; Yao Z; Ping Y; Liang T
J Nanobiotechnology; 2022 Feb; 20(1):85. PubMed ID: 35177078
[TBL] [Abstract][Full Text] [Related]
28. Induction of antigen-specific immune tolerance using biodegradable nanoparticles containing antigen and dexamethasone.
Kim SH; Moon JH; Jeong SU; Jung HH; Park CS; Hwang BY; Lee CK
Int J Nanomedicine; 2019; 14():5229-5242. PubMed ID: 31371958
[TBL] [Abstract][Full Text] [Related]
29. Substance P/dexamethasone-encapsulated PLGA scaffold fabricated using supercritical fluid process for calvarial bone regeneration.
Kim SH; Kim JE; Kim SH; Jung Y
J Tissue Eng Regen Med; 2017 Dec; 11(12):3469-3480. PubMed ID: 28568973
[TBL] [Abstract][Full Text] [Related]
30. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model.
Amoozgar Z; Wang L; Brandstoetter T; Wallis SS; Wilson EM; Goldberg MS
Biomacromolecules; 2014 Nov; 15(11):4187-94. PubMed ID: 25251833
[TBL] [Abstract][Full Text] [Related]
31. Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells.
Huang F; Zhang Q; Xiao J; Zhang X; Han X; Shi X; Hu J; Li L; Qian X
Int J Nanomedicine; 2023; 18():2261-2273. PubMed ID: 37159807
[TBL] [Abstract][Full Text] [Related]
32. Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer.
Chang CS; Ryu JY; Choi JK; Cho YJ; Choi JJ; Hwang JR; Choi JY; Noh JJ; Lee CM; Won JE; Han HD; Lee JW
J Gynecol Oncol; 2023 Sep; 34(5):e58. PubMed ID: 37170725
[TBL] [Abstract][Full Text] [Related]
33. Tumor-Antigen Activated Dendritic Cell Membrane-Coated Biomimetic Nanoparticles with Orchestrating Immune Responses Promote Therapeutic Efficacy against Glioma.
Ma X; Kuang L; Yin Y; Tang L; Zhang Y; Fan Q; Wang B; Dong Z; Wang W; Yin T; Wang Y
ACS Nano; 2023 Feb; 17(3):2341-2355. PubMed ID: 36688797
[TBL] [Abstract][Full Text] [Related]
34. Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs.
Du X; Chen K; Kuriyavar S; Kopke RD; Grady BP; Bourne DH; Li W; Dormer KJ
Otol Neurotol; 2013 Jan; 34(1):41-7. PubMed ID: 23187928
[TBL] [Abstract][Full Text] [Related]
35. High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression.
Xu L; Xia H; Ni D; Hu Y; Liu J; Qin Y; Zhou Q; Yi Q; Xie Y
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156004
[TBL] [Abstract][Full Text] [Related]
36. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
37. Cancer-associated fibroblast-targeted nanodrugs reshape colorectal tumor microenvironments to suppress tumor proliferation, metastasis and improve drug penetration.
Shen W; Yao PA; Li W; Gu C; Gao T; Cao Y; Wang Z; Pei R; Xing C
J Mater Chem B; 2023 Mar; 11(9):1871-1880. PubMed ID: 36477303
[TBL] [Abstract][Full Text] [Related]
38. Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel.
Zhang L; Shen W; Luan J; Yang D; Wei G; Yu L; Lu W; Ding J
Acta Biomater; 2015 Sep; 23():271-281. PubMed ID: 26004219
[TBL] [Abstract][Full Text] [Related]
39. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
40. [Rapid inhibition of extracellular signal-regulated kinase 1/2 in a human ovarian cancer cell line by dexamethasone].
Xia B; Lu J
Ai Zheng; 2002 Aug; 21(8):868-71. PubMed ID: 12478895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
